• Enhanced In Vitro Activity of Temafloxacin Against Gram-Posi

  2026-05-09

  This study provides a rigorous comparison of temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, with established antibiotics against Gram-positive cocci isolated from clinical blood cultures. The findings demonstrate temafloxacin’s superior in vitro potency, especially against penicillin-resistant Streptococcus pneumoniae, supporting its utility in research on Gram-positive infections and resistance.

• AM251: CB1 Receptor Antagonist Protocols for Translational R

  2026-05-08

  AM251 stands out as a potent CB1 receptor antagonist, enabling precise dissection of cannabinoid signaling in neuropharmacology and metabolic disorder models. This article delivers actionable workflows, troubleshooting, and comparative insights for leveraging AM251 in advanced neuroscience and obesity research.

• Palonosetron Hydrochloride: Precision 5-HT3 Receptor Antagon

  2026-05-07

  Palonosetron hydrochloride offers unmatched selectivity and nanomolar potency for both in vitro and in vivo 5-HT3 receptor studies, enabling advanced antiemetic and renal transporter research. This article translates recent clinical findings and bench workflows into practical, reproducible protocols for cancer research and beyond.

• Levofloxacin (SKU B1959): Precision in Cell Viability and An

  2026-05-07

  This article delivers a scenario-driven, evidence-based analysis of Levofloxacin (SKU B1959) for advanced research and cell-based assays. Drawing on quantitative data and validated protocols, it guides biomedical scientists in leveraging Levofloxacin’s reproducibility for bacterial DNA replication and bone cell metabolism studies. Benchmarks on reliability, compatibility, and workflow optimization distinguish APExBIO’s offering for researchers seeking robust assay outcomes.

• Nigericin sodium salt: Practical Guide for Ion Transport Stu

  2026-05-06

  Nigericin sodium salt enables controlled ion transport across biological membranes, facilitating research on cytoplasmic pH regulation, platelet aggregation, and selective Pb2+ ion movement. It should be used in protocols requiring precise K+/H+ exchange, but is not suitable for diagnostic or medical purposes.

• Novel PDK4 Inhibitors: Structure-Guided Advances in Metaboli

  2026-05-06

  This article reviews the discovery and characterization of a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, as presented by Jeon et al. The study highlights compound 8c's efficacy in metabolic, allergic, and oncological disease models, offering a promising direction for oral therapies targeting metabolic dysregulation.

• Linoleic Acid–PPARα Axis Drives TF-Mediated Tumor Progressio

  2026-05-05

  This study reveals that linoleic acid promotes tumor progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC) by upregulating tissue factor (TF) through PPAR-α signaling. Multiomics analysis and patient-derived xenograft models substantiate this pathway as a mechanism for immune microenvironment remodeling and suggest TF as a potential therapeutic target.

• RSL3 and the Redox–Death Axis: Unveiling GPX4 Inhibition in

  2026-05-05

  (1S,3R)-RSL3 is a potent glutathione peroxidase 4 inhibitor that induces ferroptosis in RAS-driven tumor models. This article uniquely explores the intersection of regulated cell death, redox biology, and assay design, drawing on new mechanistic insights to guide advanced cancer research.

• Thiamet G: O-GlcNAcase Inhibitor Workflows for Metabolic and

  2026-05-04

  Thiamet G is a selective O-GlcNAcase inhibitor that empowers precise, reproducible modulation of O-GlcNAcylation across neurodegenerative, oncologic, and bone disease models. This guide details advanced experimental workflows, troubleshooting strategies, and protocol enhancements to maximize your research impact.

• CHIR 99021 Trihydrochloride: GSK-3 Inhibitor for Organoid Tu

  2026-05-04

  CHIR 99021 trihydrochloride is revolutionizing organoid and metabolic research by offering precise, tunable control of stem cell fate and differentiation. Discover how optimized workflows, evidence-backed protocols, and troubleshooting strategies enable advanced modeling of insulin signaling and stem cell dynamics.

• BRD4 Inhibition Potentiates Erastin-Induced Ferroptosis via

  2026-05-03

  This study demonstrates that BRD4 inhibitors, including I-BET-762, significantly enhance erastin-induced ferroptosis across multiple cell lines by promoting ROS accumulation and downregulating FSP1. The findings clarify the epigenetic regulation of ferroptosis and suggest new combinatorial strategies for cancer therapy.

• PDK4-IN-1 Hydrochloride: Selective PDK4 Inhibition for Metab

  2026-05-02

  Explore how PDK4-IN-1 hydrochloride, a highly selective pyruvate dehydrogenase kinase 4 inhibitor, enables advanced metabolic pathway control and disease modeling. This article uniquely reveals protocol insights, practical assay decisions, and translational research opportunities.

• HDAC6-Catalyzed α-Tubulin Lactylation Links Metabolism to Cy

  2026-05-02

  This study uncovers α-tubulin lactylation at lysine 40, catalyzed by HDAC6 in response to elevated intracellular lactate, as a novel post-translational modification that enhances microtubule dynamics and neurite outgrowth. The findings establish a direct molecular connection between cellular metabolic state and cytoskeletal function, with implications for neuronal development and disease.

• Uremic Toxins and PEO Surface Density: Impacts on Protein Ad

  2026-05-01

  This study investigates how uremic toxins—specifically those retained in chronic kidney disease, such as 4-ethylphenyl sulfate—influence plasma protein adsorption on methoxy-PEO modified surfaces. Findings reveal that uremic toxins substantially increase protein adsorption regardless of PEO chain density, highlighting the need to consider disease-specific blood composition in the design of blood-contacting biomaterials.

• Mechanisms of Spiroplasma eriocheiris Entry into Drosophila

  2026-04-30

  This study reveals that Spiroplasma eriocheiris invades Drosophila S2 cells through clathrin-mediated endocytosis and macropinocytosis, rather than caveola-dependent pathways. These findings clarify the cellular entry mechanisms of an emerging invertebrate pathogen and provide a model for dissecting host-pathogen interactions at the molecular level.

452 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page